INDP Indaptus Therapeutics, Inc.
Nasdaq · SEC CIK 1857044 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 84 since 2021-08-06, latest 2026-03-24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Ben-Tzvi Avraham | Dir | — | — |
| Newman Michael James | CSO, Dir | — | — |
| Sassi Nir | CFO | — | — |
| Linscott Walt Addison | COO | — | — |
| Meckler Jeffrey A | Co-CEO, Dir, 10% | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-22 | 2026-01-20 | INDP | Ben-Tzvi Avraham | Dir | A - Grant | $0.00 | +25.0K | 25.1K | +25,000% | $0 |
| 2025-12-29 | 2025-12-22 | INDP | Sassi Nir | CFO | A - Grant | $2.03 | +26.8K | 26.8K | New | +$54.3K | |
| 2025-12-29 | 2025-12-22 | INDP | Meckler Jeffrey A | Co-CEO, Dir, 10% | A - Grant | $2.03 | +216.6K | 229.9K | +1,627% | +$439.7K | |
| 2025-12-29 | 2025-12-22 | INDP | Linscott Walt Addison | COO | A - Grant | $2.03 | +54.4K | 54.4K | +1,088,420% | +$110.5K | |
| 2025-12-29 | 2025-12-22 | INDP | Newman Michael James | CSO, Dir | A - Grant | $2.03 | +52.2K | 101.1K | +107% | +$106.0K | |
| D | 2025-07-29 | 2025-07-27 | INDP | Meckler Jeffrey A | CEO, Dir | A - Grant | $8.30 | +6,068 | 13.3K | +84% | +$50.4K |
| D | 2024-11-26 | 2024-11-25 | INDP | Meckler Jeffrey A | CEO, Dir | A - Grant | $1.18 | +42.6K | 202.9K | +27% | +$50.2K |
| D | 2024-08-08 | 2024-08-08 | INDP | Meckler Jeffrey A | CEO, Dir | A - Grant | $1.83 | +84.9K | 160.3K | +113% | +$155.4K |
| MI | 2023-08-16 | 2023-08-10+ | INDP | Anderson Glen R. | 10% | P - Purchase | $2.09 | +103.4K | 1.13M | +10% | +$216.4K |
| M | 2022-12-19 | 2022-01-31+ | INDP | Litchev Boyan Vesselinov | Chief Medical Off | P - Purchase | $2.19 | +1,150 | 150 | New | +$2,520 |
| M | 2022-11-22 | 2022-11-18+ | INDP | Meckler Jeffrey A | CEO, Dir | P - Purchase | $1.89 | +10.0K | 75.4K | +15% | +$18.9K |
| 2022-09-12 | 2022-09-08 | INDP | Meckler Jeffrey A | CEO, Dir | P - Purchase | $2.80 | +10.3K | 65.4K | +19% | +$28.9K | |
| 2022-09-09 | 2022-09-07 | INDP | Linscott Walt Addison | Chief Business Off | P - Purchase | $2.62 | +150 | 150 | New | +$393 | |
| M | 2022-09-08 | 2022-09-06+ | INDP | Meckler Jeffrey A | CEO, Dir | P - Purchase | $2.56 | +9,692 | 55.1K | +21% | +$24.8K |
| 2022-06-07 | 2022-06-06 | INDP | Meckler Jeffrey A | CEO, Dir | P - Purchase | $2.63 | +19.7K | 45.4K | +77% | +$51.9K | |
| MI | 2022-02-02 | 2022-01-31+ | INDP | Newman Michael James | CSO, Dir, 10% | S - Sale | $5.00 | -20.0K | 1.37M | -1% | -$100.0K |
| 2021-11-19 | 2021-11-18 | INDP | Meckler Jeffrey A | CEO, Dir | P - Purchase | $5.82 | +11.2K | 25.6K | +77% | +$65.1K | |
| 2021-09-16 | 2021-09-14 | INDP | Meckler Jeffrey A | CEO, Dir | P - Purchase | $7.00 | +12.0K | 14.5K | +488% | +$84.0K |
Purchase Sale Sale after option exercise All abbreviations